Home Product Alunbrig


Alunbrig (brigatinib) is classified as an anaplastic lymphoma kinase (ALK) inhibitor for the treatment of patients with certain lung cancer (ALK-positive metastatic non-small cell lung cancer (NSCLC)).

Brigatinib(Alunbrig) is used in the treatment of a certain type of lung cancer (non-small cell lung cancer) as it stops slows and spreading of cancer cells.

Side Effects of Alunbrig:

Brigatinib may cause some of these side effects:

  • Nausea/vomiting.
  • Diarrhea.
  • Decreased appetite.
  • Abdominal pain.
  • Constipation.
  • Tiredness.
  • Dizziness.
  • Fever.
  • Headache.
  • Trouble sleeping.
  • Joint pain.

If any serious side effects happen or any above effects persist or get worse, consult your doctor immediately.


There are no reviews yet.

Be the first to review “Alunbrig”

Your email address will not be published. Required fields are marked *